BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29017702)

  • 1. Collaborative study on saccharide quantification of the
    Rosskopf U; Daas A; Terao E; von Hunolstein C
    Pharmeur Bio Sci Notes; 2017; 2017():44-68. PubMed ID: 29017702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the saccharide content and stability of the first WHO International Standard for Haemophilus influenzae b capsular polysaccharide.
    Mawas F; Bolgiano B; Rigsby P; Crane D; Belgrave D; Corbel MJ
    Biologicals; 2007 Oct; 35(4):235-45. PubMed ID: 17337205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International collaborative study for establishment of the 2nd WHO International Standard for Haemophilus influenzae type b polysaccharide.
    Mawas F; Burkin K; Dougall T; Saydam M; Rigsby P; Bolgiano B;
    Biologicals; 2015 Nov; 43(6):492-503. PubMed ID: 26298195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative determination of saccharide in Haemophilus influenzae type b glycoconjugate vaccines, alone and in combination with DPT, by use of high-performance anion-exchange chromatography with pulsed amperometric detection.
    Bardotti AA; Ravenscroft NN; Ricci SS; D'Ascenzi SS; Guarnieri VV; Averani GG; Constantino PP
    Vaccine; 2000 Apr; 18(19):1982-93. PubMed ID: 10706959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High performance anion exchange chromatographic and colorimetric methods for quality assessment of total and free polysaccharide content in
    Hussein AR; Rezk MR; Fathalla FAA; El-Saharty YS; Nadim AH
    Anal Methods; 2022 Oct; 14(38):3757-3765. PubMed ID: 36106712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPAEC-PAD quantification of Haemophilus influenzae type b polysaccharide in upstream and downstream samples.
    van der Put RM; de Haan A; van den IJssel JG; Hamidi A; Beurret M
    Vaccine; 2015 Nov; 33(48):6908-13. PubMed ID: 25045809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model.
    Mawas F; Newman G; Burns S; Corbel MJ
    J Infect Dis; 2005 Jan; 191(1):58-64. PubMed ID: 15593004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a guinea-pig model for potency/immunogenicity evaluation of diphtheria, tetanus acellular pertussis (DTaP) and Haemophilus influenzae type b polysaccharide conjugate vaccines.
    Gupta RK; Anderson R; Cecchini D; Rost B; Griffin P; Benscoter K; Xu J; Montanez-Ortiz L; Siber GR
    Dev Biol Stand; 1996; 86():283-96. PubMed ID: 8785957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.
    Berrington JE; Cant AJ; Matthews JN; O'Keeffe M; Spickett GP; Fenton AC
    Pediatrics; 2006 Apr; 117(4):e717-24. PubMed ID: 16549502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and testing of a Haemophilus influenzae Type b/Hepatitis B surface antigen conjugate vaccine.
    An SJ; Woo JS; Chae MH; Kothari S; Carbis R
    Vaccine; 2015 Mar; 33(13):1614-9. PubMed ID: 25659268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of flavin mononucleotide, Haemophilus influenzae type b and its capsular polysaccharide vaccines by antibodies specific to D-ribitol-5-phosphate.
    Ravi G; Venkatesh YP
    Glycoconj J; 2014 Nov; 31(8):573-85. PubMed ID: 25108762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of low level unconjugated polysaccharide in tetanus toxoid-conjugate vaccine by HPAEC/PAD following rapid separation by deoxycholate/HCl.
    Lei QP; Lamb DH; Heller R; Pietrobon P
    J Pharm Biomed Anal; 2000 Jan; 21(6):1087-91. PubMed ID: 10708393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine.
    Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Torres V
    Pediatrics; 2007 Jan; 119(1):e179-85. PubMed ID: 17145903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
    Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination.
    Goldblatt D; Richmond P; Millard E; Thornton C; Miller E
    J Infect Dis; 1999 Aug; 180(2):538-41. PubMed ID: 10395878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
    Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of two formulations of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae conjugate-hepatitis B vaccine in 15 to 18-month-old children.
    Halperin SA; Langley JM; Hesley TM; Zappacosta PS; Radley D; Smith B; Hoffenbach A; Boslego J; Silber JL
    Hum Vaccin; 2005; 1(6):245-50. PubMed ID: 17012871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth.
    Gatchalian S; Reyes M; Bernal N; Lefevre I; David MP; Han HH; Bock HL; Wolter J; Schuerman L
    Hum Vaccin; 2005; 1(5):198-203. PubMed ID: 17012860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine.
    Pichichero ME; Passador S
    Clin Infect Dis; 1997 Dec; 25(6):1378-84. PubMed ID: 9431382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.